Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL
Official Title: Pharmacokinetics of Imlunestrant in Participants With Hepatic Impairment
Brief Summary: The main purpose of this study is to measure how much of Imlunestrant (LY3484356) gets into the bloodstream and how long it takes the body to eliminate it in female participants with impaired liver function compared to female participants with normal liver function.
The side effects and tolerability of Imlunestrant will also be evaluated.
The study may last up to 46 days for each participant.